News Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-02 EDT			After hours 19:56:22
528.04 ^USD	+6.03%		523.52	-0.86%

07-02	Vertex Pharmaceuticals Incorporated Receives Us Fda Approval for Expanded Use of Casgevy for Treatment of People Ages 2 Years and Older with Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia	CI
07-02	Vertex Pharmaceuticals Says FDA Approves Expanded Use of Casgevy in Younger Children With Blood Disorders	MT

All News

Mentions Relevance

07-02	Vertex Pharmaceuticals Incorporated Receives Us Fda Approval for Expanded Use of Casgevy for Treatment of People Ages 2 Years and Older with Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia	CI
07-02	Vertex Pharmaceuticals Says FDA Approves Expanded Use of Casgevy in Younger Children With Blood Disorders	MT
07-01	Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia	BU
07-01	US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two	RE
07-01	Vertex Pharmaceuticals Gets FDA OK for Sickle Cell Disease Treatment in Young Children	DJ
06-29	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) added to Russell 1000 Value Benchmark	CI
06-28	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 3000E Growth Benchmark	CI
06-28	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 1000 Growth Benchmark	CI
06-28	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 1000 Growth-Defensive Index	CI
06-28	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) added to Russell 3000E Value Benchmark	CI
06-28	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) added to Russell 3000 Value Benchmark	CI
06-28	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) added to Russell 1000 Value-Defensive Index	CI
06-28	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) added to Russell Top 200 Value Benchmark	CI
06-28	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell Top 200 Growth Benchmark	CI
06-28	Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 3000 Growth Benchmark	CI
06-17	Vertex Pharmaceuticals Insider Sold Shares Worth $1,827,900, According to a Recent SEC Filing	MT
06-11	Vertex's Late-Stage Clinical Data of Casgevy Deliver Crisis-Free, Transfusion-Free Results in Kids With Blood Disorders	MT
06-11	Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions	BU
06-11	Vertex Pharmaceuticals Incorporated Presents New Data on Casgevy and Announces Additional Global Regulatory Submissions	CI
06-10	Vertex Pharmaceuticals Incorporated Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 11:20 AM
06-09	Vertex Pharmaceuticals Insider Sold Shares Worth $785,250, According to a Recent SEC Filing	MT
06-05	Vertex Pharmaceuticals Incorporated Presents New Data On ALYFTREK And TRIKAFTA At European Cystic Fibrosis Conference	CI
06-05	Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference	BU
06-03	Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10	BU
06-02	Vertex Pharmaceuticals Insider Sold Shares Worth $888,300, According to a Recent SEC Filing	MT